Discovery of novel canine viral species creates opportunity for vaccine development
- Technology Benefits
- • More effective prevention of viral infections• Enhanced treatment options for viral infections• More complete understanding of viral speciesPatent information: See links below.
- Technology Application
- • Development of diagnostic methods to detect infection• Development of new vaccines against CBoV, CKoV, and CaCV-1• Elucidate mechanisms of parvovirus, picornavirus, and circovirus viral pathogenesis• Enables virology community to investigate new viral infections• Allows development of molecular reagents to identify more novel virus species
- Detailed Technology Description
- Tech Ventures Reference: IR 2801; IR 2805; IR CU12262. New canine viral species, each unique and displaying novel genetic makeup unlike existing viruses.The Canine Bocavirus (CBoV) and Canine Kobuvirus type 1 (CKoV) belong ...
- *Abstract
-
None
- *Inquiry
- Ron KatzColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- 2801
- *Principal Investigator
-
- *Publications
- • A. Kapoor, P. Simmonds, E.J. Dubovi, N. Qaisar, J.A. Henriquez, J. Medina, S. Shields, W.I. Lipkin. Characterization of a canine homolog of human aichivirus. Journal of Virology, Vol. 85, Issue 21, Nov. 2011, pp. 11520-11525. • A. Kapoor, N. Mehta, E.J. Dubovi, P. Simmonds, L. Govindasamy, J.L. Medina, C. Street, S. Shields, W.I. Lipkin. Characterization of novel canine bocaviruses and their association with respiratory disease. Journal of General Virology, Vol. 93, Issue 2, Feb. 2012, pp. 341-346. • W.I. Lipkin et al. Complete Genome Sequence of the First Canine Circovirus. Journal of Virology, Vol. 86, Issue 12, June 2012. In Press.
- *Web Links
- WIPO -- patent: WO/2012/030786WIPO -- patent: WO/2012/030778
- Country/Region
- USA
For more information, please click Here
